Novo Nordisk A/S
NONOF
$118.00
$3.963.47%
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 9.00B | 1.35B | 4.48B | 6.75B | 5.34B |
Total Receivables | 10.94B | 10.38B | 11.16B | 8.79B | 10.34B |
Inventory | 5.22B | 4.86B | 4.72B | 4.19B | 4.11B |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 339.07M | 255.71M | 347.61M | 440.55M | 381.40M |
Total Current Assets | 25.50B | 16.84B | 20.71B | 20.17B | 20.16B |
|
|||||
Total Current Assets | 25.50B | 16.84B | 20.71B | 20.17B | 20.16B |
Net Property, Plant & Equipment | 15.80B | 14.21B | 13.49B | 11.55B | 11.00B |
Long-term Investments | -- | -- | 662.00M | -- | -- |
Goodwill | -- | -- | 662.00M | -- | -- |
Total Other Intangibles | 7.97B | 8.63B | 8.30B | 7.90B | 7.44B |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 3.55B | 3.32B | 3.23B | 2.73B | 2.34B |
Total Assets | 53.07B | 43.23B | 46.64B | 42.57B | 41.15B |
|
|||||
Total Accounts Payable | 4.28B | 1.88B | 3.80B | 2.85B | 2.61B |
Total Accrued Expenses | -- | -- | 14.74B | -- | -- |
Short-term Debt | -- | -- | 67.62M | 937.97M | 921.83M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 783.31M | 1.47B | 893.05M | -- | -- |
Total Finance Division Other Current Liabilities | 21.94B | 20.60B | 5.66B | 20.68B | 19.43B |
Total Other Current Liabilities | 21.94B | 20.60B | 5.66B | 20.68B | 19.43B |
Total Current Liabilities | 27.00B | 23.95B | 25.16B | 24.47B | 22.96B |
|
|||||
Total Current Liabilities | 27.00B | 23.95B | 25.16B | 24.47B | 22.96B |
Long-Term Debt | 7.41B | 2.42B | 2.37B | 2.83B | 2.85B |
Short-term Debt | -- | -- | 67.62M | 937.97M | 921.83M |
Capital Leases | -- | -- | 675.05M | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 2.49B | 2.55B | 2.63B | 2.08B | 2.09B |
Total Liabilities | 36.90B | 28.93B | 30.83B | 29.38B | 27.89B |
|
|||||
Common Stock & APIC | 64.08M | 65.23M | 66.88M | 63.97M | 66.11M |
Retained Earnings | 16.11B | 14.33B | 15.55B | 13.01B | 12.92B |
Treasury Stock & Other | -10.63M | -85.33M | 188.49M | 114.18M | 279.08M |
Total Common Equity | 16.17B | 14.31B | 15.80B | 13.19B | 13.26B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 16.17B | 14.31B | 15.80B | 13.19B | 13.26B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 16.17B | 14.31B | 15.80B | 13.19B | 13.26B |
|